<DOC>
	<DOCNO>NCT00688532</DOCNO>
	<brief_summary>A retrospective cohort study perform GPRD , UK . All patient incident prostate cancer identify 1 Jan 1999 31 Dec 2005 frequency-matched cohort general population followed- two outcome ; CHD include acute myocardial infarction death coronary heart disease HF Dec 31 , 2006 . Outcomes validated request primary care physician . Incidence rateÂ´ratios CHD HF two cohort calculate . In cohort prostate cancer relative risk CHD HF associate use bicalutamide compare non-use estimate .</brief_summary>
	<brief_title>Study Coronary Heart Disease ( CHD ) &amp; Heart Failure ( HF ) Risk Prostate Cancer Patients , Taking Casodex Not</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>At least two year enrollment general practitioner Patients cancer start date study</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>pharmacoepidemiology study</keyword>
</DOC>